Psychiatric comorbidity among hepatitis C-positive patients

Psychosomatics

Volumn 42, Issue 5, 2001, Pages 411-415

  Yovtcheva, Sonia P ^a,b   Rifai, Muhamad ^a,b   Moles, James K ^a,b   Van der Linden, Brian J ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ILLICIT DRUG;

ADULT; AFFECTIVE NEUROSIS; AGED; ALCOHOL ABUSE; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; PERSONALITY DISORDER; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; UNITED STATES;

EID: 0034759752     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.42.5.411     Document Type: Article

References (42)

1. Drug therapy: The treatment of chronic viral hepatitis
2. Epidemiology of hepatitis C
3. The natural history of community acquired hepatitis C in the United States
4. Epidemiology of hepatitis C in the west
5. Non-A, non-B post transfusion hepatitis: Comparing C and non-C hepatitis
6. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
7. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review
8. Hepatitis C virus genotypes and quasispecies
9. Hepatitis C therapy in treatment-naive patients
10. Vulnerability to psychologic distress and depression in patients with end-stage liver disease due to hepatitis C virus
11. Epidemiology of hepatitis C in the United States
12. A study on the role of the family and other risk factors in HCV transmission
13. Routes of infection, viremia, and liver disease in asymptomatic individuals with hepatitis C virus infection
14. Management of hepatitis C
15. Seroprevalence of hepatitis C in a sample of middle class substance abusers
16. Hepatitis C virus transmission dynamics in injection drug users
17. Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis: A case-controlled study
18. The interaction of alcoholic liver disease and hepatitis C
19. Treatment of chronic hepatitis C with recombinant interferon alfa: A multicenter randomized, controlled trial
20. Effect of interferon-α treatment on chronic hepatitis C on health-related quality of life
21. Treatment with interferon-α in patients with chronic hepatitis and mood or anxiety disorders
22. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C
23. Depression, fatigue, and functional disability in patients with chronic hepatitis C
24. Morbidity of chronic hepatitis C as seen in a tertiary care medical center
25. Treatment of chronic hepatitis C in individuals with preexisting or confounding neuropsychiatric disease
26. Prophylactic treatment of depression induced by interferonα
27. Interferon alpha-induced depression in chronic hepatitis C patients: Comparison between different types of interferon alpha
28. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
29. Psychiatric patients and HIV infection: A new population at risk?
30. Psychiatric symptoms in polysubstance abusers: Relationship to race, sex, and age
31. HIV infection risks among homeless, mentally ill, chemical misusing men
32. Risk behaviors for sexually transmitted infections among men with mental disorders
33. AIDS/HIV risk behavior among the chronic mentally ill
34. Epidemiology of hepatitis C virus infection in American veterans
35. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
36. Health assessment for chronic HCV infection: Results of quality of life
37. Hepatitis C and alcohol
38. Schizophrenic psychosis: A contraindication for treatment of hepatitis C with interferon alpha?
39. Which patients with hepatitis C virus should be treated?
40. Depression during interferon therapy in chronic hepatitis C patients - A prospective study
41. Depression from intereron therapy in patients with hepatitis C